The clinical value and usage of inflammatory and nutritional markers in survival prediction for gastric cancer patients with neoadjuvant chemotherapy and D2 lymphadenectomy

Leukocytosis and neutrophilia as independent prognostic immunological biomarkers for clinical outcome in the CAO/ARO/AIO-04 randomized phase 3 rectal cancer trial

(2019) Markus Diefenhardt et al.   INTERNATIONAL JOURNAL OF CANCER

The predictive value of the preoperative C-reactive protein–albumin ratio for early recurrence and chemotherapy benefit in patients with gastric cancer after radical gastrectomy: using randomized phase III trial data

(2019) Bin-bin Xu et al.   Gastric Cancer

Gastric Lavage Malignant Cells (yGL) and Hypohemoglobinemia (yAnemia) as New Systems of Tumor Regression Grading and Prognostic Prediction for Gastric Cancer After Neoadjuvant Treatment

(2019) EDOARDO VIRGILIO et al.   ANTICANCER RESEARCH

Metabolic Alterations Induced by Kudingcha Lead to Cancer Cell Apoptosis and Metastasis Inhibition

(2019) Shenglong Zhu et al.   NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL

Prognostic importance of the preoperative modified systemic inflammation score for patients with gastric cancer

(2018) Jian-Xian Lin et al.   Gastric Cancer

Can the neutrophil-lymphocyte ratio and platelet-lymphocyte ratio be beneficial in predicting lymph node metastasis and promising prognostic markers of gastric cancer patients? Tumor maker retrospective study

(2018) Li-xiang Zhang et al.   International Journal of Surgery

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2018) Freddie Bray et al.   CA-A CANCER JOURNAL FOR CLINICIANS

A decrease in the prognostic nutritional index is associated with a worse long-term outcome in gastric cancer patients undergoing neoadjuvant chemotherapy

(2017) Kazuhiro Migita et al.   SURGERY TODAY

Peripheral venous blood neutrophil-to-lymphocyte ratio predicts survival in patients with advanced gastric cancer treated with neoadjuvant chemotherapy

(2017) Li Chen et al.   OncoTargets and Therapy

The prognostic value of neutrophil–lymphocyte ratio is superior to derived neutrophil–lymphocyte ratio in advanced gastric cancer treated with preoperative chemotherapy and sequential R0 resection: a 5-year follow-up

(2017) Hailong Jin et al.   OncoTargets and Therapy

Monocyte to lymphocyte ratio predicts survival in patients with advanced gastric cancer undergoing neoadjuvant chemotherapy

(2017) Li Chen et al.   OncoTargets and Therapy

Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†

(2016) E. C. Smyth et al.   ANNALS OF ONCOLOGY

Japanese gastric cancer treatment guidelines 2014 (ver. 4)

(2016)   Gastric Cancer

Gastric Cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology

(2016) Jaffer A. Ajani et al.   Journal of the National Comprehensive Cancer Network

The association between clinician-based common terminology criteria for adverse events (CTCAE) and patient-reported outcomes (PRO): a systematic review

(2016) Thomas M. Atkinson et al.   SUPPORTIVE CARE IN CANCER

Neutrophil Count and the Inflammation-based Glasgow Prognostic Score Predict Survival in Patients with Advanced Gastric Cancer Receiving First-line Chemotherapy

(2014) Qing-Qing Li et al.   Asian Pacific Journal of Cancer Prevention

Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial

(2011) Marc Ychou et al.   JOURNAL OF CLINICAL ONCOLOGY

Circulating lymphocyte number has a positive association with tumor response in neoadjuvant chemoradiotherapy for advanced rectal cancer

(2010) Joji Kitayama et al.   Radiation Oncology